A portfolio of essential medicines
Teralithe®
Dosages and presentations
TERALITHE® 250mg. Scored tablet. Box of 100 tablets.
THERALITE® 300mg. Tablets. Box of 50 tablets. (Colombia only).
TERALITHE® LP 400mg. Extended-release scored tablets. Box of 60 tablets.
THERALITE® 300mg. Tablets. Box of 50 tablets. (Colombia only).
TERALITHE® LP 400mg. Extended-release scored tablets. Box of 60 tablets.
Product information - Patient information leaflet
Active ingredient
Lithium carbonate
Marketing
- France
- Colombia (THERALITE® 300mg only)
- Morocco (TERALITHE® 250mg only). MA holder: Maphar
- Tunisia (TERALITHE® 250mg only)
Product news
Product available
Packaging may differ from country to country
This information is intended for healthcare professionals.
Our therapeutic areas
and our main products
Infectiology & Pneumology
Amikacin
Amukin®
France
Amoxicillin
Xyllomac®
(France)
Delamoxyle®
(Belgium - Luxembourg)
Delamoxyl®
(Switzerland)
Amoxicillin and clavulanic acid
Benzathine benzylpenicillin
Extencilline®
(France)
Extencin®
(Netherlands)
Benzylpenicillin benzathine
(United Kingdom)
N-acetylcysteine
Oxacillin
Penstapho®
(Italy)
Prostaphlin®
(Czech Republic)
Neurology
Lithium carbonate
Tropatépine hydrochloride
Pipotiazine palmitic ester
Lorazepam
Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.
REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT
To request medical information on Delbert Pharma products or report an adverse event,
please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20.